The emerging economies such as Australia and China are expected to provide a wide range of growth opportunities for players in the market which is driven by their large and growing populations as well as increase in the number of clinical trials and investments in the field of personalized medicine in these countries.
The cell therapy technologies market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025.
What Drives the Market?
1. Rising government investments in cell-based research
2. Rising incidence of chronic and infectious diseases
3. Large number of oncology-related cell therapy clinical trials
4. Increasing GMP certifications for cell therapy production facilities
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978
On the basis of cell type, the market is segmented into T-cells, stem cells, and other cells. In 2019, T-cells accounted for the largest share of the cell therapy technologies market. Favorable government initiatives and the increasing demand for T-cell therapies are the key factors driving the growth of this segment.
Request Sample Report of Cell Therapy Equipment Market @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978
This post first appeared on The Growing Applications Of Synthetic Biology Is A Major Driver For The Growth Of This Market, please read the originial post: here